Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Sep 25;123:158–162. doi: 10.1016/j.antiviral.2015.09.012

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2015 Elsevier B.V. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 1 — Effects of AMC/DCBA on PIV3. AMC/DCBA, amylmetacresol/2,4-dichlorobenzyl alcohol; PIV3, parainfluenza virus type 3; TCID₅₀, tissue culture infectious dose 50%. ^*p < 0.01 and ^**p < 0.001 compared with placebo lozenge for the same contact time. Positive control was tested at 1 min contact time only (not 10 min). Results for 5 min contact time with AMC/DCBA lozenge not shown. The error bars indicate the standard error of the mean.